 |
 |

COMMENTS & OPINIONS
Exogenous Insulin Use and Hypertension
Jaewon Oh, MD;
Ji Hyung Chung, PhD;
Yangsoo Jang, MD, PhD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The meta-analysis of the exogenous insulin use and hypertension in type 2 diabetes mellitus by Tseng1 showed that insulin users were at higher risk for development of hypertension compared with nonusers, suggesting there might be an unknown relationship between exogenous insulin use and hypertension. Hyperinsulinemia, along with insulin resistance, is a well-known risk factor for hypertension, but whether insulin itself could have the potential for the development of hypertension independent of insulin resistance is controversial. Therefore, the underlying mechanisms of insulin-induced hypertension remain to be studied further, although there are some explanations suggested by Tseng1 such as induction of oxidative stress and increased plasma catecholamine levels.
A recent basic research study might provide a novel explanation for this phenomenon. Visfatin, an adipokine, has been reported to lower plasma glucose levels through binding and activating the insulin receptor.2 Haider et . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED LETTERS
High Recurrence Rate of CA-MRSA Skin and Soft Tissue Infections
Daniel J. Skiest and Travis W. Cooper
Arch Intern Med. 2007;167(22):2527.
EXTRACT
| FULL TEXT
High Recurrence Rate of CA-MRSA Skin and Soft Tissue Infections—Reply
Lalita Shastry and Joseph Rahimian
Arch Intern Med. 2007;167(22):2527.
EXTRACT
| FULL TEXT
|